Contact

Pioneering Innovation

Our News

Amplity's new CEO Christina DiBiase
Read Now arrow
  • Press Release
  • Press Release

Amplity Names Christina DiBiase Chief Executive Officer

April 30, 2026

  • Company Updates
Filters

Filters

Type

News – Categories Filter Checkbox

Topic

News – Topics Filter Checkbox
  • Research
Imflammatory bowel disease can be treated with biologics.
Explore Research arrow

Why Patients Switch Biologics In UC & CD

May 15, 2025
  • Press Release
Find out how Amplity used its AI-powered platform to highlight key trends on GLP-1 RAs and biologics at ISPOR 25.
Read Now arrow

Amplity Unveils GLP-1 RAs & Biologic Trends At ISPOR 2025

May 15, 2025
  • Press Release
Read Article arrow

Amplity Showcases AI-Powered RWE Posters at ISPOR 2026

May 20, 2026
  • Research
Real-world research on how severity drives resource burden in OI.
Read Article arrow

How Severity Drives Resource Burden In OI

May 20, 2026
  • Research
Treatment of mNSCLC utilizes targeted therapy or chemotherapy and is often guided by molecular profiling.
Read Article arrow

Targeted Therapy Gap In EGFR+ mNSCLC

May 19, 2026
  • Press Release
Amplity's new CEO Christina DiBiase
Read Now arrow

Amplity Names Christina DiBiase Chief Executive Officer

April 30, 2026

Who You’ll Be Working With

Our Senior Leaders Are With You Every Step Of The Way →

Events and Webinars

  • Conference

American Society Of Clinical Oncology (ASCO) Annual Meeting I Chicago, IL

  • May 29, 2026
  • - Jun 2, 2026
  • May 29, 2026
  • - Jun 2, 2026

•

  • Conference
  • Conference

Future Pharma I Boston, MA

  • Jun 1, 2026
  • - Jun 2, 2026
  • Jun 1, 2026
  • - Jun 2, 2026

•

  • Conference
  • Conference

Life Sciences Trainers & Educators Network (LTEN) Annual Conference I Orlando, FL

  • Jun 15, 2026
  • - Jun 18, 2026
  • Jun 15, 2026
  • - Jun 18, 2026

•

  • Conference
Powerful Partnerships Start Here
Get in Touch